JP2004530642A5 - - Google Patents

Download PDF

Info

Publication number
JP2004530642A5
JP2004530642A5 JP2002554120A JP2002554120A JP2004530642A5 JP 2004530642 A5 JP2004530642 A5 JP 2004530642A5 JP 2002554120 A JP2002554120 A JP 2002554120A JP 2002554120 A JP2002554120 A JP 2002554120A JP 2004530642 A5 JP2004530642 A5 JP 2004530642A5
Authority
JP
Japan
Prior art keywords
psoriasis
chlorzoxazone
diagnosis
prevention
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002554120A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004530642A (ja
Filing date
Publication date
Priority claimed from DE10065475A external-priority patent/DE10065475A1/de
Application filed filed Critical
Priority claimed from PCT/EP2001/015317 external-priority patent/WO2002053171A2/de
Publication of JP2004530642A publication Critical patent/JP2004530642A/ja
Publication of JP2004530642A5 publication Critical patent/JP2004530642A5/ja
Pending legal-status Critical Current

Links

JP2002554120A 2000-12-28 2001-12-27 障害のあるケラチノサイト活性に関係する疾患を診断および処置するための中コンダクタンス型カリウムチャネルおよびモジュレーターの使用 Pending JP2004530642A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10065475A DE10065475A1 (de) 2000-12-28 2000-12-28 Verwendung von "intermediate-conductance" Kaliumkanälen und Modulatoren zur Diagnose und Behandlung von Krankheiten mit gestörter Keratinozytenfunktion
US27745301P 2001-03-20 2001-03-20
PCT/EP2001/015317 WO2002053171A2 (de) 2000-12-28 2001-12-27 Verwendung von 'intermediate-conductance kaliumkanälen und modulatoren zur diagnose und behandlung von krankheiten mit gestörter keratinozytenaktivität

Publications (2)

Publication Number Publication Date
JP2004530642A JP2004530642A (ja) 2004-10-07
JP2004530642A5 true JP2004530642A5 (enExample) 2005-12-22

Family

ID=26008117

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002554120A Pending JP2004530642A (ja) 2000-12-28 2001-12-27 障害のあるケラチノサイト活性に関係する疾患を診断および処置するための中コンダクタンス型カリウムチャネルおよびモジュレーターの使用

Country Status (5)

Country Link
EP (1) EP1345618B1 (enExample)
JP (1) JP2004530642A (enExample)
AT (1) ATE291435T1 (enExample)
CA (1) CA2433041A1 (enExample)
WO (1) WO2002053171A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10250870A1 (de) * 2002-10-31 2004-05-13 Switch Biotech Ag Zusammensetzung enthaltend Aktivatoren von IK-Kaliumkanälen und Calcineurin-Antagonisten und deren Verwendung
WO2004064835A1 (en) * 2003-01-17 2004-08-05 Neurosearch A/S Use of ion channel modulating agents for treating pain
US7851431B2 (en) * 2005-07-27 2010-12-14 Prescription Dispensing Laboratories Treatment of actinic keratoses with calcium channel blockers

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4569935A (en) * 1983-03-17 1986-02-11 University Of Tennessee Research Corp. Topical treatment of psoriasis with imidazole antibiotics
DE3563964D1 (en) * 1984-10-16 1988-09-01 Synthelabo Piperidine derivatives, their preparation and their therapeutical application
GB2273873A (en) * 1992-12-23 1994-07-06 Univ Sheffield Treatment of psoriasis
WO1997018332A1 (en) * 1995-11-13 1997-05-22 Brandeis University Regulation of cancer-causing tyrosine kinases by potassium ion conductance
US6797486B2 (en) * 1996-09-11 2004-09-28 Icagen, Incorporated Small and intermediate conductance, calcium-activated potassium channels and uses thereof
AU1224599A (en) * 1997-11-14 1999-06-07 Neurosearch A/S Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction
JPH11209302A (ja) * 1998-01-21 1999-08-03 Pola Chem Ind Inc 抗掻痒剤
WO2000033834A1 (en) * 1998-12-04 2000-06-15 Neurosearch A/S Use of isatin derivatives as ion channel activating agents
AU760250B2 (en) * 1998-12-04 2003-05-08 Neurosearch A/S New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
JP2002531539A (ja) * 1998-12-04 2002-09-24 ニューロサーチ、アクティーゼルスカブ イオンチャネル調節剤
JP2002533318A (ja) * 1998-12-22 2002-10-08 ニューロサーチ、アクティーゼルスカブ イオンチャネル調節剤

Similar Documents

Publication Publication Date Title
JP2003503454A5 (enExample)
CY2020003I2 (el) Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις για την θεραπευτικη αγωγη της παθολογιας του crohn
NO20034612L (no) 3,4-di-substituerte syklobuten-1,2-dioner, farmasoytiske preparater som omfatter forbindelsene, samt anvendelse av forbindelsene for tilvirkning av medikamenter for behandling av kjemokinformidlede sykdommer
JP2002532112A5 (enExample)
NO20016427L (no) Blandinger og fremgangsmåter for behandling av diagnose av lungekreft
CA2407371A1 (en) Quinazoline derivatives for the treatment of tumours
CA2392879A1 (en) A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders
NO324227B1 (no) Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer
MY129809A (en) Quinazoline derivatives
BR9711194A (pt) Uso de agente quelante clioquinol para a fabricação de uma composição farmacêutica para o tratamento de doença de alzheimer.
FI20000720A7 (fi) Pitkitettyyn vapautumiseen perustuva tablettiformulaatio Parkisonin taudin hoitamiseksi
BRPI0408655A (pt) formulações compreendendo um agente ativo e cacau em pó e a sua utilização
EE200300216A (et) Radiofarmatseutilised ained Alzheimeri tõve diagnoosimiseks
EE200100179A (et) Farmatseutilised agendid Parkinsoni tõve, ADHD jamikroadenoomide raviks
JP2004517824A5 (enExample)
JP2005509503A5 (enExample)
PL364086A1 (en) Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases
JP2004505922A5 (enExample)
MXPA03006776A (es) Uso de inhibidores de interleucina-18 para el tratamiento y/o prevencion de enfermedad cardiaca.
JP2004530642A5 (enExample)
AU2003303217A8 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
NO20042476L (no) Anvendelse av desoxypeganin for behandling av klinisk depresjon
AU4418400A (en) Treatment, imaging and diagnosis of disease using an agent which binds alfa5-integrin
JP2005505605A5 (enExample)
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer